Health-related quality of life for kidney cancer patients on pembrolizumab/lenvatinib
In this video, Dr Bradley McGregor from the Dana-Farber Cancer [...]
Immunotherapy and COVID-19 in cancer patients
A recent review published in the Journal for ImmunoTherapy of [...]
FDA approves belzutifan for VHL kidney cancer
The FDA has approved a new drug called belzutifan for [...]
FDA approves pembrolizumab plus lenvatinib combination for advanced kidney cancer
The US Food and Drug Administration (FDA) has approved the [...]
